In studies not testing for therapeutic effect, high-concentration THC products had unfavorable links with psychosis, schizophrenia
Psychedelics and cannabis may offer treatment hope for eating disorder symptoms
Black non-Hispanic teens less likely to complete treatment, while Hispanic, Asian, Native Hawaiian/Pacific Islander more likely than Whites
After addition of anxiety as qualifying condition, 60.26 percent of certifications were for anxiety
Prevalence of delta-9-tetrahydrocannabinol, cannabidiol, and synthetic cannabinoids vaping higher for girls than boys
Past-year mental health treatment and community supervision involvement tied to receiving treatment
Notable shifts seen among those with higher income and certain clinical conditions
Vaping and dabbing are the most prevalent routes of use among persons aged 18 to 24 years
Compared with those with all-cause hospital-based care and the general population, risk increased for those with cannabis use-based care